中国药房Issue(22):3025-3028,4.DOI:10.6039/j.issn.1001-0408.2015.22.01
政府研发资助、内部研发投入与制药企业创新绩效的关系研究
Study on the Relation of the Government Subsidies and Internal Input to R & D and the Innovation Perfor-mance of Pharmaceutical Enterprises
摘要
Abstract
OBJECTIVE:To provide a reference for promoting the effect of government subsidies to the R&D conducted by pharmaceutical enterprises,increasing enterprises’internal input to R&D and improving innovation performance. METHODS:By building the theoretical model of the relation of the government subsidies and internal input to R&D and the innovation performance on the basis of the assumptions,the empirical study was conducted on the pharmaceutical enterprises in Jiangsu Province though re-gression analysis and mediating effect analysis. RESULTS & CONCLUSIONS:The scale designed had good reliability and validity. The final model was obtained after empirical test. Giving considerations to relevant coefficients,the results showed that all assump-tions were verified except 3. Where,government subsidies to the R&D promoted enterprises’internal input to R&D and innovation performance,and internal input to R&D served as a complete mediator between government subsidies to the R&D and innovation performance,that is to say,government subsidies to the R&D had indirect promotion influence on innovation performance,with the influence coefficient as 0.405. It is suggested that the government should increase subsidies to R&D conducted by pharmaceuti-cal enterprises in a reasonable manner to make full use of the guiding function of government funds,and pharmaceutical enterprises should attach importance to internal input to R&D and establish its principal status in innovation system.关键词
制药企业/政府研发资助/内部研发投入/创新绩效/中介效应Key words
Pharmaceutical enterprises/Government subsidies to the R&D/Internal input to R&D/Innovation performance/Mediating effect分类
医药卫生引用本文复制引用
张世娟,冯国忠..政府研发资助、内部研发投入与制药企业创新绩效的关系研究[J].中国药房,2015,(22):3025-3028,4.基金项目
江苏省2014年度普通高校研究生科研创新计划项目 ()